| Biopharmaceuticals is a related branch of | | | | are some recombinant proteins such as recombinant |
| Pharmaceutical engineering. Biopharmaceutical plants | | | | antibodies (rAbs) and monoclonal antibodies (Mabs) |
| use the concepts of biotechnology to develop | | | | which are highly in demand as they are highly |
| medicines. Some of the living organisms especially | | | | potential and can cure various diseases. |
| belonging to plant origin have great healing capacities. | | | | Biopharmaceutical plants accounts for the 40% of |
| Biopharmaceutical plants use these plants and other | | | | the total production of these highly potential |
| botanical sources to develop medicines. | | | | recombinant proteins. It is also working in other key |
| There is a huge demand of safe and recombinant | | | | areas such as transplant, auto-immunity and other |
| proteins. These proteins are highly potential and can | | | | cardiovascular disorders. |
| cure a number of diseases. Insulin, growth hormones | | | | With the advent of pathogenesis, pharmaceutical |
| and red blood cell stimulating agents can cure many | | | | engineering has made a huge success. This technique |
| diseases such as multiple sclerosis, arthritis and other | | | | can potentially solve many diseases and can increase |
| orphan diseases. Thus the main aim of pharmaceutical | | | | the life span of the sufferers. Biotechnology has |
| engineering is to produce more and more | | | | given many solutions to medical world. The major |
| recombinant proteins to develop solutions for a | | | | challenge faced by these plants is that it needs a |
| number of diseases. | | | | huge investment cost. Hence, pharmaceutical |
| At present, there are about 80 biopharmaceutical | | | | manufacturing industries are trying hard to make |
| plants in the market and around 500 are under their | | | | cost-effective medicines so that it can be affordable |
| development stages and yet to be launched. There | | | | by everyone. |